Citadel Advisors - RECRO PHARMA INC ownership

RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 53 filers reported holding RECRO PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of RECRO PHARMA INC
ValueSharesWeighting
Q3 2023$32,701
-65.5%
69,725
-19.2%
0.00%
Q2 2023$94,872
-3.3%
86,247
+4.6%
0.00%
Q1 2023$98,150
+124.8%
82,479
+181.5%
0.00%
Q4 2022$43,657
-80.9%
29,300
-79.1%
0.00%
Q3 2022$229,000
+59.0%
140,460
-22.7%
0.00%
Q2 2022$144,000
-66.7%
181,678
-24.3%
0.00%
Q1 2022$432,000
+14.3%
239,841
+8.4%
0.00%
Q4 2021$378,000
-39.9%
221,164
-27.6%
0.00%
Q3 2021$629,000
-2.6%
305,486
+9.1%
0.00%
Q2 2021$646,000
+26.4%
279,887
+53.0%
0.00%
Q1 2021$511,000
+396.1%
182,954
+407.7%
0.00%
Q4 2020$103,000
+58.5%
36,034
+153.8%
0.00%
Q2 2020$65,000
-90.0%
14,200
-82.2%
0.00%
Q1 2020$651,000
-64.0%
79,706
-19.1%
0.00%
-100.0%
Q4 2019$1,806,000
+1171.8%
98,538
+603.8%
0.00%
Q2 2019$142,000
-17.4%
14,000
-52.1%
0.00%
Q1 2019$172,000
+77.3%
29,258
+113.7%
0.00%
Q4 2018$97,000
-57.6%
13,692
-57.4%
0.00%
Q3 2018$229,000
+81.7%
32,149
+181.6%
0.00%
Q1 2018$126,00011,4180.00%
Other shareholders
RECRO PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Samjo Capital LLC 8,039,100$3,770,3381.48%
First Light Asset Management, LLC 19,676,396$9,228,2300.88%
AWM Investment Company, Inc. 10,266,144$4,814,8220.71%
Caligan Partners LP 1,689,768$794,1910.36%
HighMark Wealth Management LLC 484,985$227,4580.19%
Nantahala Capital Management 1,250,000$586,2500.05%
Clear Harbor Asset Management, LLC 938,847$440,3190.05%
DRIEHAUS CAPITAL MANAGEMENT LLC 4,249,229$1,992,8880.03%
TITLEIST ASSET MANAGEMENT, LLC 210,148$98,5590.02%
ROYCE & ASSOCIATES LP 3,285,082$1,540,7030.02%
View complete list of RECRO PHARMA INC shareholders